Balsalazide disodium en es it fr

Balsalazide disodium Brand names, Balsalazide disodium Analogs

Balsalazide disodium Brand Names Mixture

  • No information avaliable

Balsalazide disodium Chemical_Formula

C17H15N3O6

Balsalazide disodium RX_link

http://www.rxlist.com/cgi/generic2/balsalazide.htm

Balsalazide disodium fda sheet

Balsalazide_disodium FDA

Balsalazide disodium msds (material safety sheet)

Balsalazide disodium Synthesis Reference

No information avaliable

Balsalazide disodium Molecular Weight

357.318 g/mol

Balsalazide disodium Melting Point

No information avaliable

Balsalazide disodium H2O Solubility

Freely soluble as disodium salt

Balsalazide disodium State

Solid

Balsalazide disodium LogP

2.417

Balsalazide disodium Dosage Forms

Capsule (750 mg)

Balsalazide disodium Indication

For the treatment of mildly to moderately active ulcerative colitis.

Balsalazide disodium Pharmacology

Balsalazide is a prodrug that is enzymatically cleaved in the colon to produce mesalamine (5-aminosalicylic acid), an anti inflammatory drug indicated for the treatment of mildly to moderately active ulcerative colitis. Balsalazide disodium is delivered intact to the colon where it is cleaved by bacterial azoreduction to release equimolar quantities of mesalamine, which is the therapeutically active portion of the molecule, and 4-aminobenzoyl-(beta)-alanine.

Balsalazide disodium Absorption

Low and variable, intact balsalazide is poorly absorbed systemically.

Balsalazide disodium side effects and Toxicity

A single oral dose of balsalazide disodium at 5 grams/kg or 4-aminobenzoyl-(beta)-alanine, a metabolite of balsalazide disodium, at 1 gram/kg was non-lethal in mice and rats. No symptoms of acute toxicity were seen at these doses.

Balsalazide disodium Patient Information

No information avaliable

Balsalazide disodium Organisms Affected

Humans and other mammals